Evidence map›Paper›PMID 40670940›Full record

ArticleBMC microbiology2025

Antimicrobial resistance and virulence gene profiles of Escherichia coli isolated from poultry farms using One Health perspective in Abeokuta, Nigeria.

A T Ajibola, M de Lagarde, O E Ojo, S A Balogun, G Vanier, J M Fairbrother, O B Shittu

Abstract read
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Characterization of antimicrobial-resistantOpen veterinary journal · 2025
    Article
  8. Antimicrobial resistance ofFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

A T AjibolaMicrobiology Department, College of Biosciences, Federal University of Agriculture, Abeokuta, P.M.B 2240, Abeokuta, 110111, Nigeria. oladotun_abiola@yahoo.com.
M de LagardeOMSA Reference Laboratory for Escherichia Coli, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC, J2S2M2, Canada.
O E OjoDepartment of Veterinary Microbiology, College of Veterinary Medicine, Federal University of Agriculture, Abeokuta, Nigeria.
S A BalogunMicrobiology Department, College of Biosciences, Federal University of Agriculture, Abeokuta, P.M.B 2240, Abeokuta, 110111, Nigeria.
G VanierOMSA Reference Laboratory for Escherichia Coli, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC, J2S2M2, Canada.
J M FairbrotherOMSA Reference Laboratory for Escherichia Coli, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC, J2S2M2, Canada.
O B ShittuMicrobiology Department, College of Biosciences, Federal University of Agriculture, Abeokuta, P.M.B 2240, Abeokuta, 110111, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial resistant Extraintestinal pathogenic Escherichia coli (ExPEC) includes uropathogenic E. coli (UPEC), the causative agents of urinary tract infections (UTI), neonatal meningitis E. coli (NMEC), implicated in neonatal meningitis in humans, and avian pathogenic E. coli (APEC). Antimicrobial resistant ExPEC infections are associated with economic losses in poultry worldwide. However, few studies have been done on ExPEC in Nigeria.

methodsIn order to gain further insight into the presence of antimicrobial resistant ExPEC in poultry and the putative transmission of E. coli isolates from healthy chickens to poultry owners and/or the environment, antimicrobial susceptibility testing (AST) and polymerase chain reaction (PCR) to determine the presence of 5 virulence genes considered as ExPEC predictors were carried out on 71 E. coli isolates from apparently healthy chickens, their handlers and their shared environment, in Abeokuta, Ogun State, Nigeria. In addition, 14 of the 71 isolates were characterized using whole genome sequencing.

resultsRegardless of the source, 70.4% of the isolates were multidrug-resistant (MDR) and 66.2% of the isolates were resistant to fluoroquinolones. Only 3 out of the 71 isolates had at least 2 ExPEC predictor genes and the proportion of antimicrobial resistance (AMR) was higher in isolates with at least 1 ExPEC predictor gene. Thirty different resistance determinants were identified from the 14 whole genome sequenced isolates and most of the sequenced isolates harbored plasmid-mediated resistance genes, including aph(3″)-Ib, aph(6)-Id, floR, sul1, sul2, tet(A), and tet(B). Isolates were very diverse, 11 different serotypes and 12 different sequence types being detected in this study. Twenty different replicons were also found, IncF1B being the most frequently detected. Different ExPEC virulent genes and virulence associated genes (VAGs) for iron acquisition, toxin production, invasion and other virulence determinants were detected.

conclusionsOur results suggest that apparently healthy birds carry antimicrobial resistant genes and virulence genes, underlining their possible transmission to humans. The presence of similar ARGs and VAGs in the handlers of birds and their shared environment highlights the importance of using a One Health approach.

Indexed as

Drug Resistance, BacterialEscherichia coliEscherichia coli InfectionsPoultry DiseasesVirulence FactorsAnimalsAnti-Bacterial AgentsChickensDrug Resistance, Multiple, BacterialFarmsMicrobial Sensitivity TestsNigeriaOne HealthPoultryVirulenceWhole Genome SequencingAnti-Bacterial AgentsVirulence FactorsAntimicrobial resistanceEscherichia coliExPECOne HealthPoultry

Identifiers

PMID40670940
PMCPMC12265224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.